HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Biddinger, S. B. Articles by Kahn, C. R. Search for Related Content PubMed PubMed Citation Articles by Biddinger, S. B. Articles by Kahn, C. R. Social Bookmarking                What's this?

Leptin Suppresses Stearoyl-CoA Desaturase 1 by Mechanisms Independent of Insulin and Sterol Regulatory Element–Binding Protein-1c

¹ Research Division, Joslin Diabetes Center, Boston, Massachusetts
² Department of Medicine, Harvard Medical School, Boston, Massachusetts
³ Division of Endocrinology, Children’s Hospital, Boston, Massachusetts
⁴ Department of Biochemistry, University of Wisconsin, Madison, Wisconsin
⁵ Department of Nutritional Sciences, University of Wisconsin, Madison, Wisconsin

Address correspondence and reprint requests to C. Ronald Kahn, Research Division, Joslin Diabetes Center, One Joslin Pl., Boston, MA 02215. E-mail: c.ronald.kahn{at}joslin.harvard.edu

Abbreviations: ACC, acetyl-CoA carboxylase; CNS, central nervous system; IRS, insulin receptor substrate; LXR, liver X receptor; MCH, melanin-concentrating hormone; MUFA, monounsaturated fatty acid; SCD, stearoyl-CoA desaturase; SFA, saturated fatty acid; SREBP; sterol regulatory element–binding protein

Stearoyl-CoA desaturase (SCD)1 catalyzes the rate-limiting reaction of monounsaturated fatty acid (MUFA) synthesis and plays an important role in the development of obesity. SCD1 is suppressed by leptin but induced by insulin. We have used animal models to dissect the effects of these hormones on SCD1. In the first model, leptin-deficient ob/ob mice were treated with either leptin alone or with both leptin and insulin to prevent the leptin-mediated fall in insulin. In the second model, mice with a liver-specific knockout of the insulin receptor (LIRKO) and their littermate controls (LOXs) were treated with leptin. As expected, leptin decreased SCD1 transcript, protein, and activity by >60% in ob/ob and LOX mice. However, the effects of leptin were not diminished by the continued presence of hyperinsulinemia in ob/ob mice treated with both leptin and insulin or the absence of insulin signaling in LIRKO mice. Furthermore, genetic knockout of sterol regulatory element–binding protein (SREBP)-1c, the lipogenic transcription factor that mediates the effects of insulin on SCD1, also had no effect on the ability of leptin to decrease either SCD1 transcript or activity. Thus, the effect of leptin on SCD1 in liver is independent of insulin and SREBP-1c, and leptin, rather than insulin, is the major regulator of hepatic MUFA synthesis in obesity-linked diabetes.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. E. Cohen, E. Kokkotou, S. B. Biddinger, T. Kondo, R. Gebhardt, J. Kratzsch, C. S. Mantzoros, and C. R. Kahn High Circulating Leptin Receptors with Normal Leptin Sensitivity in Liver-specific Insulin Receptor Knock-out (LIRKO) Mice J. Biol. Chem., August 10, 2007; 282(32): 23672 - 23678. [Abstract] [Full Text] [PDF]